Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Population Pharmacodynamic Analysis of Uric Acid-Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals.

Muraki S, Moriki K, Shigematsu S, Fukae M, Kakara M, Yamashita D, Hirota T, Takane H, Shimada M, Hirakawa M, Ieiri I.

J Clin Pharmacol. 2018 Mar;58(3):304-313. doi: 10.1002/jcph.1023. Epub 2017 Oct 18.

PMID:
29045766
2.

Successful Plasma Exchange for Acute Pancreatitis Complicated With Hypertriglyceridemia: A Case Report.

Takahira S, Suzuki H, Watanabe Y, Kin H, Ooya Y, Sekine Y, Sonoda K, Ogawa H, Nomura Y, Takane H, Tsuchiya Y, Tsukamoto I, Nemoto M.

J Investig Med High Impact Case Rep. 2015 Sep 10;3(3):2324709615605635. doi: 10.1177/2324709615605635. eCollection 2015 Jul-Sep.

3.

Blood glucose levels in peritoneal dialysis are better reflected by HbA1c than by glycated albumin.

Watanabe Y, Ohno Y, Inoue T, Takane H, Okada H, Suzuki H.

Adv Perit Dial. 2014;30:75-82.

PMID:
25338425
4.

Long-term survival benefits of combined hemodialysis and peritoneal dialysis.

Suzuki H, Hoshi H, Inoue T, Kikuta T, Takane H, Takenaka T, Watanabe Y, Okada H, Kimura Y.

Adv Perit Dial. 2014;30:31-5.

PMID:
25338419
5.

Home hemodialysis and conventional in-center hemodialysis in Japan: a comparison of health-related quality of life.

Watanabe Y, Ohno Y, Inoue T, Takane H, Okada H, Suzuki H.

Hemodial Int. 2014 Oct;18 Suppl 1:S32-8. doi: 10.1111/hdi.12221.

PMID:
25330829
6.

Calcium channel blockers suppress daily variations of blood pressure in hypertensive patients with end-stage renal diseases.

Takenaka T, Sueyoshi K, Arai J, Watanabe Y, Takane H, Ohno Y, Suzuki H.

Clin Exp Hypertens. 2014;36(2):78-82. doi: 10.3109/10641963.2014.892116.

PMID:
24625333
7.

Statin improves flow-mediated vasodilation in chronic kidney diseases.

Takenaka T, Takane H, Kikuta T, Watanabe Y, Suzuki H.

Int J Hypertens. 2013;2013:876865. doi: 10.1155/2013/876865. Epub 2013 Dec 11.

8.

Association between DNA methylation in the miR-328 5'-flanking region and inter-individual differences in miR-328 and BCRP expression in human placenta.

Saito J, Hirota T, Furuta S, Kobayashi D, Takane H, Ieiri I.

PLoS One. 2013 Aug 21;8(8):e72906. doi: 10.1371/journal.pone.0072906. eCollection 2013.

9.

Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy on hemodialysis.

Takenaka T, Okayama M, Kojima E, Nodaira Y, Arai J, Uchida K, Kikuta T, Sueyoshi K, Hoshi H, Watanabe Y, Takane H, Suzuki H.

Clin Exp Hypertens. 2013;35(4):244-9. doi: 10.3109/10641963.2013.780066. Epub 2013 Mar 27.

PMID:
23534458
10.

Continuous ambulatory Peritoneal dialysis beyond a decade: cases from a single center.

Nobe K, Inoue T, Nodaira Y, Kimura Y, Okayama M, Gen S, Seto T, Sueyoshi K, Takane H, Takenaka T, Okada H, Suzuki H.

Adv Perit Dial. 2012;28:74-8.

PMID:
23311218
11.

Aging is an important risk factor for peritoneal dialysis-associated peritonitis.

Okayama M, Inoue T, Nodaira Y, Kimura Y, Nobe K, Seto T, Sueyoshi K, Takane H, Takenaka T, Okada H, Suzuki H.

Adv Perit Dial. 2012;28:50-4.

PMID:
23311213
12.

Aliskiren reduces morning blood pressure in hypertensive patients with diabetic nephropathy.

Takenaka T, Nobe K, Okayama M, Kojima E, Nodaira Y, Sueyoshi K, Hoshi H, Watanabe Y, Takane H, Suzuki H.

Clin Exp Hypertens. 2012;34(4):243-8. doi: 10.3109/10641963.2012.681080. Epub 2012 May 4.

PMID:
22559034
13.

Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney disease: a randomized controlled study.

Takenaka T, Seto T, Okayama M, Kojima E, Nodaira Y, Sueyoshi K, Kikuta T, Watanabe Y, Inoue T, Takane H, Ohno Y, Suzuki H.

Am J Nephrol. 2012;35(5):416-23. doi: 10.1159/000338132. Epub 2012 Apr 20.

PMID:
22517217
14.

Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues.

Hirota T, Date Y, Nishibatake Y, Takane H, Fukuoka Y, Taniguchi Y, Burioka N, Shimizu E, Nakamura H, Otsubo K, Ieiri I.

Lung Cancer. 2012 Jul;77(1):16-23. doi: 10.1016/j.lungcan.2011.12.018. Epub 2012 Feb 3.

PMID:
22306127
15.

Validation of carotid blood pressure assessment by tonometry.

Takenaka T, Kikuta T, Watanabe Y, Inoue T, Takane H, Ohno Y, Suzuki H.

J Hypertens. 2012 Feb;30(2):429-32; author reply 432. doi: 10.1097/HJH.0b013e32834c7af9. No abstract available.

PMID:
22236973
16.

Removal of the peritoneal dialysis catheter because of gastrointestinal disease in patients on continuous ambulatory peritoneal dialysis: a single-center case series.

Kojima E, Inoue T, Sueyoshi K, Sato T, Tsuda M, Kikuta T, Watanabe Y, Takane H, Takenaka T, Suzuki H.

Adv Perit Dial. 2011;27:77-81.

PMID:
22073834
17.

Clinical presentation in patients more than 80 years of age at the start of peritoneal dialysis.

Sueyoshi K, Inoue T, Kojima E, Sato T, Tsuda M, Kikuta T, Watanabe Y, Takane H, Takenaka T, Suzuki H.

Adv Perit Dial. 2011;27:71-6.

PMID:
22073833
18.

[Genetic polymorphisms of SLCO1B1 for drug pharmacokinetics and its clinical implications].

Takane H.

Yakugaku Zasshi. 2011;131(11):1589-94. Review. Japanese.

19.

Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.

Takenaka T, Uchida K, Kojima E, Gen S, Nodaira Y, Hoshi H, Kato N, Takane H, Ohno Y, Suzuki H.

Clin Exp Hypertens. 2011;33(4):210-5. doi: 10.3109/10641963.2011.583965.

PMID:
21699446
20.

Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.

Sasaki T, Takane H, Ogawa K, Isagawa S, Hirota T, Higuchi S, Horii T, Otsubo K, Ieiri I.

Antimicrob Agents Chemother. 2011 May;55(5):1867-73. doi: 10.1128/AAC.01185-10. Epub 2011 Feb 28.

21.

Risk factors for health care-associated pneumonia: transmission of multidrug-resistant Pseudomonas aeruginosa isolates from general hospitals to nursing homes.

Fujimura S, Nakano Y, Takane H, Kikuchi T, Watanabe A.

Am J Infect Control. 2011 Mar;39(2):173-5. doi: 10.1016/j.ajic.2010.06.020. No abstract available.

PMID:
21356435
22.

Height constitutes an important predictor of mortality in end-stage renal disease.

Takenaka T, Sato T, Hoshi H, Kato N, Sueyoshi K, Tsuda M, Watanabe Y, Takane H, Ohno Y, Suzuki H.

Cardiol Res Pract. 2010 Nov 11;2011:242353. doi: 10.4061/2011/242353.

23.

Antibacterial activity of carbapenems against clinical isolates of respiratory bacterial pathogens in the northeastern region of Japan in 2007.

Gomi K, Fujimura S, Fuse K, Takane H, Nakano Y, Kariya Y, Kikuchi T, Kurokawa I, Tokue Y, Watanabe A.

J Infect Chemother. 2011 Apr;17(2):200-6. doi: 10.1007/s10156-010-0112-2. Epub 2010 Sep 14.

PMID:
20839026
24.

Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus.

Fujimura S, Fuse K, Takane H, Nakano Y, Gomi K, Kikuchi T, Watanabe A.

J Infect Chemother. 2011 Feb;17(1):30-3. doi: 10.1007/s10156-010-0094-0. Epub 2010 Jul 28.

PMID:
20665064
25.

Seasonal variations of daily changes in blood pressure among hypertensive patients with end-stage renal diseases.

Takenaka T, Kojima E, Sueyoshi K, Sato T, Uchida K, Arai J, Hoshi H, Kato N, Takane H, Suzuki H.

Clin Exp Hypertens. 2010 Jul;32(4):227-33. doi: 10.3109/10641963.2010.491887.

PMID:
20608893
26.

Asthma: Chronopharmacotherapy and the molecular clock.

Burioka N, Fukuoka Y, Koyanagi S, Miyata M, Takata M, Chikumi H, Takane H, Watanabe M, Endo M, Sako T, Suyama H, Ohdo S, Shimizu E.

Adv Drug Deliv Rev. 2010 Jul 31;62(9-10):946-55. doi: 10.1016/j.addr.2010.03.012. Epub 2010 Mar 30. Review.

PMID:
20359514
27.

Zigzagged augmentation index in diabetes.

Takenaka T, Sato T, Hoshi H, Kato N, Sueyoshi K, Kobayashi K, Takane H, Kanno Y, Ohno Y, Suzuki H.

Clin Exp Hypertens. 2009 Nov;31(8):657-68. doi: 10.3109/10641960903407025.

PMID:
20001458
28.

In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa.

Fujimura S, Takane H, Nakano Y, Watanabe A.

J Antimicrob Chemother. 2009 Nov;64(5):1115-6. doi: 10.1093/jac/dkp333. Epub 2009 Sep 10. No abstract available.

PMID:
19744981
29.

Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases.

Takenaka T, Takane H, Okada H, Ohno Y, Suzuki H.

NDT Plus. 2009 Apr;2(2):192-3. doi: 10.1093/ndtplus/sfp014. No abstract available.

30.

Cardio-ankle vascular index to screen cardiovascular diseases in patients with end-stage renal diseases.

Takenaka T, Hoshi H, Kato N, Kobayashi K, Takane H, Shoda J, Suzuki H.

J Atheroscler Thromb. 2008 Dec;15(6):339-44. Epub 2008 Dec 6.

31.

Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy.

Takane H, Kawamoto K, Sasaki T, Moriki K, Moriki K, Kitano H, Higuchi S, Otsubo K, Ieiri I.

Cancer Chemother Pharmacol. 2009 May;63(6):1165-9. doi: 10.1007/s00280-008-0864-x. Epub 2008 Nov 8.

PMID:
18998132
32.

Polymorphism in human organic cation transporters and metformin action.

Takane H, Shikata E, Otsubo K, Higuchi S, Ieiri I.

Pharmacogenomics. 2008 Apr;9(4):415-22. doi: 10.2217/14622416.9.4.415. Review.

PMID:
18384255
33.

Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.

Hirota T, Takane H, Higuchi S, Ieiri I.

Curr Drug Metab. 2008 Jan;9(1):34-8. Review.

PMID:
18220569
34.

Severe toxicities after irinotecan-based chemotherapy in a patient with lung cancer: a homozygote for the SLCO1B1*15 allele.

Takane H, Miyata M, Burioka N, Kurai J, Fukuoka Y, Suyama H, Shigeoka Y, Otsubo K, Ieiri I, Shimizu E.

Ther Drug Monit. 2007 Oct;29(5):666-8.

PMID:
17898662
35.

Salt and excess food intake produced diabetic nephropathy in Japan.

Takane H, Kanno Y, Ohno Y, Sugahara S, Suzuki H.

Contrib Nephrol. 2007;155:125-135. doi: 10.1159/000101005.

PMID:
17369720
36.

Elevation of plasma D-dimer is closely associated with venous thrombosis produced by double-lumen catheter in pre-dialysis patients.

Kanno Y, Kobayashi K, Takane H, Arima H, Ikeda N, Shoda J, Suzuki H.

Nephrol Dial Transplant. 2007 Apr;22(4):1224-7. Epub 2007 Feb 3.

PMID:
17277337
37.

Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin.

Shikata E, Yamamoto R, Takane H, Shigemasa C, Ikeda T, Otsubo K, Ieiri I.

J Hum Genet. 2007;52(2):117-22. Epub 2006 Nov 17.

PMID:
17111267
38.

Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.

Ieiri I, Takane H, Hirota T, Otsubo K, Higuchi S.

Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):651-74. Review.

PMID:
17014387
39.

Continuous ambulatory peritoneal dialysis is effective for patients with severe congestive heart failure.

Takane H, Nakamoto H, Arima H, Shoda J, Moriwaki K, Ikeda N, Kobayashi K, Kanno Y, Sugahara S, Okada H, Suzuki H.

Adv Perit Dial. 2006;22:141-6.

PMID:
16983958
40.

Long-term follow-up of patients treated with a combination of continuous ambulatory peritoneal dialysis and hemodialysis.

Hoshi H, Nakamoto H, Kanno Y, Takane H, Ikeda N, Sugahara S, Okada H, Suzuki H.

Adv Perit Dial. 2006;22:136-40.

PMID:
16983957
41.

Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy.

Takane H, Miyata M, Burioka N, Shigemasa C, Shimizu E, Otsubo K, Ieiri I.

J Hum Genet. 2006;51(9):822-6. Epub 2006 Aug 18.

PMID:
16917677
42.

Glucocorticoid regulation of 24-hour oscillation in interferon receptor gene expression in mouse liver.

Koyanagi S, Suyama H, Kuramoto Y, Matsunaga N, Takane H, Soeda S, Shimeno H, Higuchi S, Ohdo S.

Endocrinology. 2006 Nov;147(11):5034-40. Epub 2006 Aug 17.

PMID:
16916957
43.

Multiple gene polymorphisms and warfarin sensitivity.

Shikata E, Ieiri I, Ishiguro S, Takane H, Ohgi S, Otsubo K.

Eur J Clin Pharmacol. 2006 Oct;62(10):881-3. Epub 2006 Jul 4. No abstract available.

PMID:
16821005
44.

The influence of granisetron on the pharmacokinetics and pharmacodynamics of docetaxel in Asian lung cancer patients.

Miyata M, Yasuda K, Burioka N, Takane H, Suyama H, Shigeoka Y, Endo M, Kurai J, Morita M, Igishi T, Shimizu E.

Cancer J. 2006 Jan-Feb;12(1):69-72.

PMID:
16613665
45.

Rifampin reduces the analgesic effect of transdermal fentanyl.

Takane H, Nosaka A, Wakushima H, Hosokawa K, Ieiri I.

Ann Pharmacother. 2005 Dec;39(12):2139-40. Epub 2005 Nov 15. No abstract available.

PMID:
16288064
46.

Dexamethasone influences human clock gene expression in bronchial epithelium and peripheral blood mononuclear cells in vitro.

Burioka N, Takata M, Okano Y, Ohdo S, Fukuoka Y, Miyata M, Takane H, Endo M, Suyama H, Shimizu E.

Chronobiol Int. 2005;22(3):585-90.

PMID:
16076656
47.

[Treatment recommendations for various stages in diabetic nephropathy].

Takane H, Suzuki H.

Nihon Rinsho. 2005 Jun;63 Suppl 6:379-83. Review. Japanese. No abstract available.

PMID:
15999738
48.

Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects.

Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi S, Otsubo K, Sugiyama Y.

Hepatol Res. 2004 Oct;30(2):91-95.

PMID:
15519273
49.

An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate.

Okada H, Watanabe Y, Kotaki S, Ikeda N, Takane H, Kanno Y, Sugahara S, Ban S, Nagata M, Suzuki H.

Am J Kidney Dis. 2004 Nov;44(5):902-7.

PMID:
15492957
50.

Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, Suzuki H, Nanba E, Oshimura M, Terakawa N, Otsubo K, Mine K, Sugiyama Y.

Drug Metab Dispos. 2005 Jan;33(1):94-101. Epub 2004 Oct 8.

PMID:
15475413

Supplemental Content

Loading ...
Support Center